Royalty Pharma Common Stock Net 2019-2025 | RPRX

Royalty Pharma common stock net for the quarter ending March 31, 2025 was $0.000B, a 1.85% decline year-over-year.

  • Royalty Pharma common stock net for 2024 was $0B, a 0% decline from 2023.
  • Royalty Pharma common stock net for 2023 was $0B, a 0.93% increase from 2022.
  • Royalty Pharma common stock net for 2022 was $0B, a 0.94% increase from 2021.

Royalty Pharma Common Stock Net 2019-2025 | RPRX

  • Royalty Pharma common stock net for 2024 was $0B, a 0% decline from 2023.
  • Royalty Pharma common stock net for 2023 was $0B, a 0.93% increase from 2022.
  • Royalty Pharma common stock net for 2022 was $0B, a 0.94% increase from 2021.